Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease.
暂无分享,去创建一个
S. Potkin | J. Wu | J. Fallon | Joseph C. Wu | D. Keator | K. Fleming | G. Alva | D. Carreon | J C Wu | S G Potkin | R. Anand | R. Hartman | J H Fallon | R Anand | K Fleming | G Alva | D Keator | D Carreon | J Messina | R Hartman | J. Messina | D. Carreon
[1] J. Hatazawa,et al. Can PET Data Differentiate Alzheimer's Disease from Vascular Dementia? , 2000, Annals of the New York Academy of Sciences.
[2] M. Weinstock,et al. Selectivity of Cholinesterase Inhibition , 1999 .
[3] S. Minoshima,et al. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease , 1999, Neurology.
[4] G. Alexander,et al. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study. , 1999, The American journal of psychiatry.
[5] D. Kuhl,et al. Neurochemical imaging of Alzheimer's disease and other degenerative dementias. , 1998, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[6] S. Rapoport,et al. Discriminant Analysis of Brain Imaging Data Identifies Subjects With Early Alzheimer's Disease , 1997, International Psychogeriatrics.
[7] H. Wiśniewski,et al. Contribution of Structural Neuroimaging to the Early Diagnosis of Alzheimer's Disease , 1997, International Psychogeriatrics.
[8] Cheuk Y. Tang,et al. Decreasing Striatal 6-FDOPA Uptake with Increasing Duration of Cocaine Withdrawal , 1997, Neuropsychopharmacology.
[9] Eileen O. Smith,et al. The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer’s disease , 1997, Psychopharmacology.
[10] H Lundqvist,et al. Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment. , 1997, Dementia and geriatric cognitive disorders.
[11] J V Haxby,et al. Network analysis of PET-mapped visual pathways in Alzheimer type dementia. , 1995, Neuroreport.
[12] A. Nordberg. Effect of long‐term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET , 1993, Acta neurologica Scandinavica. Supplementum.
[13] K. Herholz,et al. Activation PET as an Instrument to Determine Therapeutic Efficacy in Alzheimer's Disease a , 1993, Annals of the New York Academy of Sciences.
[14] K. Herholz,et al. Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PET a , 1991, Annals of the New York Academy of Sciences.
[15] S. Kitamura,et al. [Measurements of cerebral blood flow and metabolism in patients with Alzheimer's disease]. , 1990, Rinsho byori. The Japanese journal of clinical pathology.
[16] M. Torrens. Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .
[17] James V. Haxby,et al. Abnormalities of regional brain metabolism in Alzheimer's disease and their relation to functional impairment , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[18] W. Heiss,et al. Zerebraler Glukosestoffwechsel bei präseniler Demenz vom Alzheimer-Typ - Verlaufskontrolle unter Therapie mit muskarinergem Cholinagonisten - , 1986 .
[19] B. L. Beattie,et al. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. , 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[20] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[21] J. G. Snodgrass,et al. A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity, and visual complexity. , 1980, Journal of experimental psychology. Human learning and memory.
[22] E. Hoffman,et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.
[23] D. Perani. The role of emission tomography in dementia , 1999, The Italian Journal of Neurological Sciences.
[24] R Mielke,et al. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia. , 1998, Journal of neural transmission. Supplementum.
[25] Scott T. Grafton,et al. Automated image registration: I. General methods and intrasubject, intramodality validation. , 1998, Journal of computer assisted tomography.
[26] S Pollack,et al. The resampling method of statistical analysis. , 1994, Psychopharmacology bulletin.
[27] J. Mazziotta,et al. Automated image registration , 1993 .
[28] W. Heiss,et al. [Cerebral glucose metabolism in presenile dementia of the Alzheimer type--follow-up of therapy with muscarinergic choline agonists]. , 1986, Fortschritte der Neurologie-Psychiatrie.
[29] A. Hirano,et al. AN ATLAS OF THE HUMAN BRAIN FOR COMPUTERIZED TOMOGRAPHY. , 1978 .
[30] Karl J. Friston,et al. Comparing Functional (PET) Images: The Assessment of Significant Change , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.